D-Street Newsmakers: BSE, Mankind Pharma, Swiggy among 7 stocks that hogged limelight today

Indian equities in Thursday's session (December 19) fell sharply with the BSE 30-share Sensex index slipping below 80,000 levels, while the Nifty50 index gave up 24,000 levels. Broader markets, however, outperformed the headline indices. 

Prashanth Tapse, Senior VP (Research), Mehta Equities said, "Markets were plundered tracking negative global cues as benchmark indices slipped below their psychological levels on broad-based selling after the US Fed's hawkish stance raised concerns over further rate cuts next year."

Rising US bond yields have pushed global currencies, including the rupee to new lows while renewed foreign fund outflows from domestic equities could prompt investors to turn risk-averse, cautioned the expert.

Bank Nifty also plunged over 1 per cent or more than 550 points led by losses in index heavyweights including ICICI Bank, HDFC Bank and Axis Bank among others.

Here are the stocks that remained in focus in Thursday's session:

Spicejet: After an amicable settlement with Genesis, wherein Genesis would acquire some stake in the air-carrier, the stock ended higher by nearly 9 per cent at Rs 61.33. At the day's high, the stock touched levels of Rs 61.99 per share.

Swiggy: After global brokerages initiated coverage on the food delivery services firm, the scrip ended 0.85 per cent higher at Rs 582.25 per share on the BSE.

Mankind Pharma: Defying overall weak market sentiment, pharma stocks witnessed buoyancy and in this backdrop Mankind Pharma after notching a new 52-week high ended around 3 per cent higher at Rs 2.889.45 apiece on the BSE.

Inventurus Knowledge Solutions: After making a stellar debut, the stock ended 48 per cent higher at Rs 1,960.85 per share. Zee Business Managing Editor advised booking profits after listing gains.

BSE: The scrip in intraday trade marked its fresh 52-week high price and settled higher by nearly 3 per cent at Rs 5.796 per share.

Tata Consumer Products: The scrip ended in the red at Rs 906.65 even as the company denied report claiming ‘Starbucks to Exit India Due to High Costs, Bad Taste’ as baseless. 

Ipca Laboratories: The stock ended with gains of over 5 per cent at Rs 1,595.35 per share after the company's promoter Usha Madhukar Chandurkar on the previous day divested a 1.6 per cent stake for Rs 600 crore through an open market transaction.